Skip to main content
. Author manuscript; available in PMC: 2022 May 7.
Published in final edited form as: Am J Addict. 2019 Jun 4;28(4):238–245. doi: 10.1111/ajad.12904

Table 1:

Baseline characteristics of sample, by baseline use of nonprescribed opioids

Pretreatment nonprescribed opioid use
N=71
No nonprescribed opioid use pretreatment
N=49
Total
N=120
Categorical variables, number (%) n % % % df F or X2 p-value

Assigned to galantamine 31 44 24 49 55 46 1 .33 .57
Female 19 27 21 43 40 33 1 3.38 .07
Race and ethnicity
  Caucasian 35 49 27 55 62 52 3 1.54 .67
  African-American 14 20 11 22 25 21
  Hispanic 21 30 11 22 32 27
  Multiracial 1 1 0 1 1
Completed high school 53 75 33 67 86 72 1 .76 .38
Unemployed 54 76 33 67 87 73 1 1.10 .29
On public assistance 51 72 34 69 85 71 1 .08 .77
Major depression -Lifetimea 5 7 5 10 10 8 1 .38 .54
Anxiety disorder -Lifetime 10 14 5 10 15 13 1 .40 .53
Antisocial personality disorder 9 13 7 14 16 13 1 .07 .80
Alcohol use disorder-lifetime 38 54 28 57 66 55 1 .15 .70
Post traumatic stress disorder 2 3 1 2 3 3 1 .07 .79
Continuous variables, mean and SD M SD M SD M SD
Days paid for working, past 28 8.41 9.89 6.18 9.49 7.50 9.75 1, 118 1.52 .22
Age 38.41 9.27 38.29 9.74 38.36 9.43 1, 118 .01 .94
Days marijuana use, past 28 3.56 7.11 2.84 7.70 3.27 7.34 1, 118 .28 .60
Days cocaine use, past 28 14.00 8.30 14.33 8.44 14.13 8.32 1, 118 .04 .83
Days cigarette use, past 28 26.27 6.53 26.53 5.98 26.38 6.29 1, 118 .05 .82
Days alcohol use, past 28 3.30 6.46 1.59 3.59 2.60 5.52 1, 118 2.81 .10
Days benzodiazepine use, past 28 .45 1.39 .20 .71 .35 1.16 1, 118 1.30 .26
Years of regular cocaine use 9.87 8.75 9.69 8.36 9.80 8.56 1, 118 .01 .91
Years of regular opiate use 10.77 7.57 8.57 8.09 9.88 7.83 1, 118 2.32 .13
Lifetime number of arrests 7.86 10.45 6.51 11.30 7.31 10.78 1, 118 .45 .50
Prior Treatment Episodes:
  Number of outpatient episodes 2.87 3.52 2.35 2.50 2.66 3.14 1, 118 .81 .37
  Number of inpatient episodes 3.96 6.10 1.78 2.49 3.07 5.06 1, 118 5.60 .02
Estimated IQ from Shipley 100.71 11.62 100.31 11.84 100.55 11.67 1, 118 .03 .85
Baseline methadone dose, mg/day 68.10 29.00 73.65 28.01 70.45 28.60 1, 118 1.07 .30
Posttreatment methadone dose, mg. day 67.77 31.17 71.04 34.15 69.11 32.32 1, 115 .29 .59

a

All psychiatric diagnoses from SCID interviews